Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 72

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 72
---
View Common Stock of $11.71 on OTC Pink Sheets on February 6, 2025. 
 The Sponsor also beneficially owns 5,162,500 private placement warrants, for which it paid $5,162,500 and which will expire and be worthless if NorthView does not complete a business combination.                                                                                                                                                                                                                                                                                                        |     | As of the expected closing date of the Business Combination, the Sponsor will have lent to NorthView an estimated $1.9 million pursuant to interest-free loans, including for funds deposited in the Trust Account in connection with extensions of the deadline by which NorthView had to consummate its initial business combination. These loans are due to be repaid at closing. These loans are due to be repaid at closing, but are expected to be converted into shares of New Profusa Common Stock at a price of $2.22 per share. |
| I-Bankers and Dawson James |     | I-Bankers and Dawson James, the managing underwriters of NorthView’s IPO, together beneficially own 450,000 representative shares of NorthView Common Stock, which shares would become worthless if NorthView does not complete a business combination                                                                                                                                                                                                                                                     |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

This compensation will not result in a material dilution of the equity interests of non -redeemingshareholders who hold the securities until the consummation of the de -SPACtransaction. See the section entitled “ Proposal No. 1 — The Business Combination Proposal — Interests of NorthView’s Directors, and Officers and Initial Stockholders in the Business Combination”. Reasons for the Approval of the Business Combination After careful consideration, NorthView’s Board recommends that NorthView Holders vote “FOR” each proposal being submitted to a vote of the NorthView Holders at the special meeting. For a description of NorthView’s reasons for the approval of the Business Combination and the recommendation of NorthView’s Board, see the section entitled “ The Business Combination — The NorthView Board’s Reasons for the Approval of the Business Combination”. Redemption Rights Pursuant to NorthView’s Amended and Restated Certificate of Incorporation, we are providing our public stockholders with the opportunity to redeem all or a portion of their public shares of NorthView Common Stock for cash upon consummation of the Business Combination. The per share redemption price will be equal to the aggregate amount then on deposit in the Trust Account that holds the proceeds of our IPO, including interest (net of taxes payable), divided by the number of then outstanding